Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

Lynn Quek, Muriel D. David, Alison Kennedy, Marlen Metzner, Michael Amatangelo, Alan H. Shih, Bilyana Stoilova, Cyril Quivoron, Maël Heiblig, Christophe Willekens,

Nature Medicine · 2018 · 200 citations · 52 references

DOIFull text

Open access

Concepts

References

52